We reported previously that TRPM7 is an indirect regulator of the FOSL1 gene where high expression of FOSL1 elevates glioma cell proliferation and invasion; FOSL1 is also associated with poor survival in GBM patients [6]. The gene discussed is FOSL1; the disease is central nervous system cancer.